Home > News > ACLARA Receives 4 U.S. Patents
April 5th, 2004
ACLARA Receives 4 U.S. Patents
ACLARA BioSciences announced the issuance of four U.S. patents that strengthen the intellectual property around its eTag technology: Nos. 6,682,887 and No. 6,686,152 with claims related to certain eTag applications; No. 6,673,550 with broad claims related to certain specific eTag reporter molecules including assays related to protein and protein complex expression; and No. 6,685,813 with claims related to eTag sample handling in a nanofluidic setting.
Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014
Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine October 30th, 2014
Lomiko Signs Licensing Agreement to Produce and Supply Power Converter Systems to E-Commerce Customers October 29th, 2014
Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014